TriSalus Life Sciences, Inc. is an oncology-focused medical technology company that develops innovative drug delivery technologies for solid tumors. Its flagship product, the TriNav Infusion System, uses Pressure-Enabled Drug Delivery (PEDD) technology for interventional radiology procedures including TACE and TARE. The company also develops nelitolimod, an investigational TLR9 agonist, and the PRVI device for pancreatic tumor treatment, generating $45.2 million in TriNav revenue in 2025.
Q2 FY2026 — expected 2026-09-23
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-05 | 2025-12-31 | 0001628280-26-015163 | EDGAR | 85K words |
| 2025-04-15 | 2024-12-31 | 0001826667-25-000030 | EDGAR | 106K words |
| 2024-04-11 | 2023-12-31 | 0001826667-24-000005 | EDGAR | 126K words |
| 2023-03-22 | 2022-12-31 | 0001410578-23-000332 | EDGAR | — |
| 2022-03-03 | 2021-12-31 | 0001410578-22-000252 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001104659-21-044719 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001628280-26-054275 | EDGAR | 24K words |
| 2025-11-13 | 2025-09-30 | 0001628280-25-052043 | EDGAR | 25K words |
| 2025-08-12 | 2025-06-30 | 0001826667-25-000117 | EDGAR | 33K words |
| 2025-05-15 | 2025-03-31 | 0001826667-25-000051 | EDGAR | 31K words |
| 2024-11-14 | 2024-09-30 | 0001826667-24-000051 | EDGAR | 75K words |
| 2024-08-14 | 2024-06-30 | 0001826667-24-000039 | EDGAR | 73K words |
| 2024-05-15 | 2024-03-31 | 0001826667-24-000017 | EDGAR | 66K words |
| 2023-11-14 | 2023-09-30 | 0001826667-23-000007 | EDGAR | 77K words |
| 2023-08-02 | 2023-06-30 | 0001410578-23-001525 | EDGAR | 26K words |
| 2023-05-12 | 2023-03-31 | 0001410578-23-001035 | EDGAR | 21K words |
| 2022-11-10 | 2022-09-30 | 0001410578-22-003118 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0001410578-22-002206 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-22 | 0001628280-26-063031 | EDGAR | 1K words |
| 2026-08-06 | 0001628280-26-054264 | EDGAR | 4K words |
| 2026-03-05 | 0001628280-26-015155 | EDGAR | 5K words |
| 2026-02-20 | 0001493152-26-007598 | EDGAR | 1K words |
| 2026-02-09 | 0001628280-26-006219 | EDGAR | 1K words |
| 2026-01-12 | 0001628280-26-001743 | EDGAR | 1K words |
| 2025-11-13 | 0001628280-25-052008 | EDGAR | 5K words |
| 2025-10-01 | 0001628280-25-043440 | EDGAR | 1K words |
| 2025-08-29 | 0001826667-25-000129 | EDGAR | 1K words |
| 2025-08-12 | 0001826667-25-000115 | EDGAR | 4K words |
131 total filings indexed. 103 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001826667 |
| Ticker | TLSI |
| Exchange | Nasdaq |
| SIC | 3841: Surgical & Medical Instruments & Apparatus |
| Incorporated | DE |
| Website | https://www.trisaluslifesci.com |
| Listed | 2023-08-11 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/TLSI (~200 tokens, structured JSON with cryptographic provenance)